 |
 |

Panretinal Photocoagulation in the Treatment of Vitreoretinal Amyloidosis
Arch Ophthalmol. 1998;116:1534.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
We performed vitrectomy on both eyes of a patient with bilateral vitreoretinal amyloidosis. In one eye, concurrent panretinal photocoagulation prevented recurrence.
Report of a Case
In August 1991, a 52-year-old African American woman complained of floaters in both eyes. Visual acuity was 20/25 OD and 20/20 OS. Results of ophthalmic examination showed no abnormalities, except for acellular vitreous opacities, and no treatment was advised. By June 1992, visual acuity had decreased to 20/40 OU, consistent with increased vitreous opacities and the diagnosis of probable amyloidosis was made.
Pars plana vitrectomy was performed in the left eye in July 1992. Histopathologic stains were consistent with amyloidosis. The patient's postoperative visual acuity improved to 20/20 OS, but amyloidosis has a high recurrence rate.1 Vitrectomy in the right eye was performed in August 1992, with concomitant endolaser panretinal photocoagulation to destroy the possible site of production or secretion. In May 1993, the patient was symptom free with . . . [Full Text of this Article] Comment
Reprints: Michael D. Baum, MD, 8830 Cameron St, Silver Spring, MD 20910.
|